Skip to main content
Caplight Logo









LensGen

LensGen

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://lensgen.com/

Last Round

Corporate Funding

Mar 2, 2023

Est. Valuation

$100M

Total Funding Raised

$41.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LensGen is an ophthalmic medical device company that has developed a biomimetic, fluid-optic intraocular lens for the treatment of cataracts and presbyopia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

accommodating IOLintraocular lensIOLpresbyopia treatmentpresbyopia correcting IOLcataract surgeryophthalmic medical devicefluid-optic lensshape-changing lensclinical stage medical devicebiomimetic lenspremium IOLInvestigational Device ExemptionIDEmodular IOL

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LensGen Comparables

Compare LensGen with similar companies based on industry and business-model similarity.

LensGen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atia Vision
93%
Adaptilens
90%
JelliSee Ophthalmics Inc.
89%

LensGen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 2, 2023
Series BAug 20, 2020
Series AMay 1, 2017

LensGen Investors

Notable investors and investment history

LensGen investors
InvestorRounds
ExSight VenturesSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 304% MoM, reaching 3K.

  • May 16, 2026

    Monthly visitors grew 55% MoM, from 826 to 1.3K.

LensGen Filings

Explore SEC and related filing metadata, where available.

LensGen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LensGen's valuation, stock price, and market status.

Is LensGen a public or private company?

LensGen is a private company.

What is the current stock price of LensGen?

LensGen is a private company with no public stock price. No recent secondary market data is available.

How much is LensGen worth (valuation)?

Valuation information for LensGen is not publicly available.

Can I buy LensGen stock?

LensGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LensGen's last funding round?

Funding round information for LensGen is not publicly available.

Who are the main investors in LensGen?

Investor information for LensGen is not publicly disclosed.

Will LensGen IPO soon?

No public IPO plans have been announced for LensGen.

How can I track LensGen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LensGen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range10
Year Founded2011
Last FundingMar 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?